메뉴 건너뛰기




Volumn 11, Issue 12, 2010, Pages 1645-1648

RAF kinase inhibitors in cancer treatment: Like a bull in a China shop?

Author keywords

Antitumor agents; Chemical biology; Drug development; Signaling

Indexed keywords

2 [4 (1 HYDROXYIMINO 5 INDANYL) 3 (4 PYRIDINYL) 1H PYRAZOL 1 YL]ETHANOL; 2 [4 (2 DIMETHYLAMINOETHOXY)PHENYL] 4 (1 HYDROXYIMINO 5 INDANYL) 5 (4 PYRIDINYL) 1H IMIDAZOLE; 3 (3,5 DIBROMO 4 HYDROXYBENZYLIDENE) 1,3 DIHYDRO 5 IODO 2 INDOLONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; AZ 628; B RAF KINASE; B RAF KINASE INHIBITOR; JAB 13; JAB 34; L 779450; MITOGEN ACTIVATED PROTEIN KINASE; N [5 (3 DIMETHYLAMINOBENZAMIDO) 2 METHYLPHENYL] 4 HYDROXYBENZAMIDE; PLX 4032; PLX 4720; RAS PROTEIN; SORAFENIB; UNCLASSIFIED DRUG;

EID: 77955637293     PISSN: 14394227     EISSN: 14397633     Source Type: Journal    
DOI: 10.1002/cbic.201000348     Document Type: Short Survey
Times cited : (1)

References (23)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.